DGAP-News

STADA: Good start in the first quarter of 2013 - organic growth accelerated

DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous
STADA: Good start in the first quarter of 2013 - organic growth
accelerated

07.05.2013 / 07:25

---------------------------------------------------------------------

Important items at a glance
- Adjusted EBITDA increases - despite the high comparable basis - to Euro
98.5 million (+7 percent) - adjusted EBITDA margin at a high level with
20.7 percent - reported EBITDA increases to Euro 96.9 million (+25
percent)
- Group sales rise to Euro 477.0 million (+8 percent) - organic growth
records growth to 4 percent
- Substantial sales rise in branded products (+21 percent)
- Significant sales increase in the market region CIS/Eastern Europe -
particularly in Russia (+39 percent) and Serbia (+22 percent)
- Temporary increase in the tax rate leads to a decrease in adjusted net
income by 7 percent - reported net income increases by 80 percent
- Outlook to 2014 confirmed

STADA Key Figures

1-3/2013 1-3/2012 +/-

Group sales 477.0 443.4 +8%
Operating profit 71.0 46.2 +54%
Operating profit, adjusted 73.0 67.9 +8%
EBITDA (Earnings before interest, taxes, 96.9 77.2 +25%
depreciation and amortization)
EBITDA, adjusted 98.5 92.3 +7%
Net income 34.9 19.4 +80%
Net income, adjusted 36.7 39.3 -7%
Earnings per share 0.59 0.33 +79%
Earnings per share, adjusted 0.62 0.67 -7%


Bad Vilbel, May 7, 2013 - In the first quarter of 2013, STADA Arzneimittel
AG was able to increase both the Group sales as well as all reported key
earnings figures. Organic growth increased to 4 percent.

'We are very satisfied with our good start in the first quarter of 2013 and
thus remain on a good path towards being able to achieve our long-term
prognosis in 2014. In addition to an increase in Group sales in the amount
of 8 percent, we were also able to achieve an acceleration in organic
growth with 4 percent in the first three months of the current financial
year. Contributing to this were the very successful developments in Russia
and Serbia as well as in some Western European countries such as France and
Italy, but also a strong sales plus of 21 percent in branded products',